Altered Prefrontal Cortical Metabolic Response to Mesocortical Activation in Adult Animals with a Neonatal Ventral Hippocampal Lesion

Biological Psychiatry

Volumn 60, Issue 6, 2006, Pages 585-590

  Tseng, Kuei Y ^a   Amin, Fatema ^a   Lewis, Barbara L ^a   O'Donnell, Patricio ^a  

^a ALBANY MEDICAL COLLEGE   (United States)

Author keywords

Cytochrome oxidase; hypofrontality; neonatal ventral hippocampal lesion; prefrontal cortex; schizophrenia; ventral tegmental area

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DAMAGE; BRAIN DEPTH STIMULATION; BRAIN METABOLISM; COMPARATIVE STUDY; CONTROLLED STUDY; DENSITOMETRY; ENZYME ANALYSIS; FEMALE; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; MALE; NEUROPATHOLOGY; NEWBORN; NEWBORN DISEASE; NONHUMAN; PREFRONTAL CORTEX; PREPUBERTY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; VENTRAL TEGMENTUM;

ANALYSIS OF VARIANCE; ANIMALS; ANIMALS, NEWBORN; BEHAVIOR, ANIMAL; BRAIN INJURIES; ELECTRIC STIMULATION; ELECTRON TRANSPORT COMPLEX IV; FUNCTIONAL LATERALITY; HIPPOCAMPUS; HISTOCYTOCHEMISTRY; MALE; PREFRONTAL CORTEX; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS; VENTRAL TEGMENTAL AREA;

EID: 33748756522     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2006.03.030     Document Type: Article

References (41)

1. Becker A., Grecksch G., Bernstein H.G., Hollt V., and Bogerts B. Social behaviour in rats lesioned with ibotenic acid in the hippocampus: Quantitative and qualitative analysis. Psychopharmacology (Berl) 144 (1999) 333-338
2. Braver T.S., Cohen J.D., Nystrom L.E., Jonides J., Smith E.E., and Noll D.C. A parametric study of prefrontal cortex involvement in human working memory. Neuroimage 5 (1997) 49-62
3. Callicott J.H., Bertolino A., Mattay V.S., Langheim F.J., Duyn J., Coppola R., et al. Physiological dysfunction of the dorsolateral prefrontal cortex in schizophrenia revisited. Cereb Cortex 10 (2000) 1078-1092
4. Callicott J.H., Egan M.F., Mattay V.S., Bertolino A., Bone A.D., Verchinksi B., et al. Abnormal fMRI response of the dorsolateral prefrontal cortex in cognitively intact siblings of patients with schizophrenia. Am J Psychiatry 160 (2003) 709-719
5. Callicott J.H., Mattay V.S., Bertolino A., Finn K., Jones K., Frank J.A., et al. Physiological characteristics of capacity constraints in working memory as revealed by functional MRI. Cereb Cortex 9 (1999) 20-26
6. Callicott J.H., Mattay V.S., Verchinski B.A., Marenco S., Egan M.F., and Weinberger D.R. Complexity of prefrontal cortical dysfunction in schizophrenia: More than up or down. Am J Psychiatry 160 (2003) 2209-2215
7. Chambers R.A., Moore J., McEvoy J.P., and Levin E.D. Cognitive effects of neonatal hippocampal lesions in a rat model of schizophrenia. Neuropsychopharmacology 15 (1996) 587-594
8. Chrapusta S.J., Egan M.F., Wyatt R.J., Weinberger D.R., and Lipska B.K. Neonatal ventral hippocampal damage modifies serum corticosterone and dopamine release responses to acute footshock in adult Sprague-Dawley rats. Synapse 47 (2003) 270-277
9. Goldberg T.E., Berman K.F., Fleming K., Ostrem J., Van Horn J.D., Esposito G., et al. Uncoupling cognitive workload and prefrontal cortical physiology: A PET rCBF study. Neuroimage 7 (1998) 296-303
10. Goldman-Rakic P. Regional and cellular fractionation of working memory. Proc Natl Acad Sci USA 93 (1996) 13473-13480
11. Goto Y., and O'Donnell P. Prefrontal lesion reverses abnormal mesoaccumbens response in an animal model of schizophrenia. Biol Psychiatry 55 (2004) 172-176
12. Hevner R.F., Liu S., and Wong-Riley M.T. A metabolic map of cytochrome oxidase in the rat brain: Histochemical, densitometric and biochemical studies. Neuroscience 65 (1995) 313-342
13. Hevner R.F., and Wong-Riley M.T. Regulation of cytochrome oxidase protein levels by functional activity in the macaque monkey visual system. J Neurosci 10 (1990) 1331-1340
14. Hevner R.F., and Wong-Riley M.T. Neuronal expression of nuclear and mitochondrial genes for cytochrome oxidase (CO) subunits analyzed by in situ hybridization: Comparison with CO activity and protein. J Neurosci 11 (1991) 1942-1958
15. Hirsch E.C., Perier C., Orieux G., Francois C., Feger J., Yelnik J., et al. Metabolic effects of nigrostriatal denervation in basal ganglia. Trends Neurosci 23 10 Suppl (2000) S78-S85
16. Honey G.D., Bullmore E.T., and Sharma T. De-coupling of cognitive performance and cerebral functional response during working memory in schizophrenia. Schizophr Res 53 (2002) 45-56
17. Le Pen G., and Moreau J.L. Disruption of prepulse inhibition of startle reflex in a neurodevelopmental model of schizophrenia: Reversal by clozapine, olanzapine and risperidone but not by haloperidol. Neuropsychopharmacology 27 (2002) 1-11
18. Lewis B.L., and O'Donnell P. Ventral tegmental area afferents to the prefrontal cortex maintain membrane potential "up" states in pyramidal neurons via D1 dopamine receptors. Cereb Cortex 10 (2000) 1168-1175
19. Lipska B.K., al-Amin H.A., and Weinberger D.R. Excitotoxic lesions of the rat medial prefrontal cortex. Effects on abnormal behaviors associated with neonatal hippocampal damage. Neuropsychopharmacology 19 (1998) 451-464
20. Lipska B.K., Aultman J.M., Verma A., Weinberger D.R., and Moghaddam B. Neonatal damage of the ventral hippocampus impairs working memory in the rat. Neuropsychopharmacology 27 (2002) 47-54
21. Lipska B.K., Chrapusta S.J., Egan M.F., and Weinberger D.R. Neonatal excitotoxic ventral hippocampal damage alters dopamine response to mild repeated stress and to chronic haloperidol. Synapse 20 (1995) 125-130
22. Lipska B.K., Jaskiw G.E., and Weinberger D.R. Postpubertal emergence of hyperresponsiveness to stress and to amphetamine after neonatal excitotoxic hippocampal damage: A potential animal model of schizophrenia. Neuropsychopharmacology 9 (1993) 67-75
23. Lipska B.K., Lerman D.N., Khaing Z.Z., Weickert C.S., and Weinberger D.R. Gene expression in dopamine and GABA systems in an animal model of schizophrenia: Effects of antipsychotic drugs. Eur J Neurosci 18 (2003) 391-402
24. Lipska B.K., Lerman D.N., Khaing Z.Z., and Weinberger D.R. The neonatal ventral hippocampal lesion model of schizophrenia: Effects on dopamine and GABA mRNA markers in the rat midbrain. Eur J Neurosci 18 (2003) 3097-3104
25. Lipska B.K., and Weinberger D.R. Subchronic treatment with haloperidol and clozapine in rats with neonatal excitotoxic hippocampal damage. Neuropsychopharmacology 10 (1994) 199-205
26. Lipska B.K., and Weinberger D.R. Prefrontal cortical and hippocampal modulation of dopamine-mediated effects. Adv Pharmacol 42 (1998) 806-809
27. Lipska B.K., and Weinberger D.R. To model a psychiatric disorder in animals: Schizophrenia as a reality test. Neuropsychopharmacology 23 (2000) 223-239
28. Manoach D.S. Prefrontal cortex dysfunction during working memory performance in schizophrenia: Reconciling discrepant findings. Schizophr Res 60 (2003) 285-298
29. Manoach D.S., Gollub R.L., Benson E.S., Searl M.M., Goff D.C., Halpern E., et al. Schizophrenic subjects show aberrant fMRI activation of dorsolateral prefrontal cortex and basal ganglia during working memory performance. Biol Psychiatry 48 (2000) 99-109
30. Manoach D.S., Press D.Z., Thangaraj V., Searl M.M., Goff D.C., Halpern E., et al. Schizophrenic subjects activate dorsolateral prefrontal cortex during a working memory task as measured by fMRI. Biol Psychiatry 45 (1999) 1128-1137
31. Murer M.G., Dziewczapolski G., Salin P., Vila M., Tseng K.Y., Ruberg M., et al. The indirect basal ganglia pathway in dopamine D(2) receptor-deficient mice. Neuroscience 99 (2000) 643-650
32. O'Donnell P. Dopamine gating of forebrain neural ensembles. Eur J Neurosci 17 (2003) 429-435
33. O'Donnell P., and Grace A.A. Dysfunctions in multiple interrelated systems as the neurobiological bases of schizophrenic symptom clusters. Schizophr Bull 24 (1998) 267-283
34. O'Donnell P., Lewis B.L., Weinberger D.R., and Lipska B.K. Neonatal hippocampal damage alters electrophysiological properties of prefrontal cortical neurons in adult rats. Cereb Cortex 12 (2002) 975-982
35. rd ed. (1997), Academic, London
36. Tseng K.Y., Kloc M., Lewis B.L., and O'Donnell P. Changes in D2 dopaminergic modulation of prefrontal cortical GABAergic interneurons during adolescence and in a developmental animal model of schizophrenia. Society for Neuroscience Abstracts 31 (2005) 444 .1.
37. Tseng K.Y., and O'Donnell P. Dopamine-glutamate interactions controlling prefrontal cortical pyramidal cell excitability involve multiple signaling mechanisms. J Neurosci 24 (2004) 5131-5139
38. Tseng K.Y., and O'Donnell P. Post-pubertal emergence of prefrontal cortical up states induced by D1-NMDA co-activation. Cereb Cortex 15 (2005) 49-57
39. Vila M., Perier C., Feger J., Yelnik J., Faucheux B., Ruberg M., et al. Evolution of changes in neuronal activity in the subthalamic nucleus of rats with unilateral lesion of the substantia nigra assessed by metabolic and electrophysiological measurements. Eur J Neurosci 12 (2000) 337-344
40. Wong-Riley M.T. Changes in the visual system of monocularly sutured or enucleated cats demonstrable with cytochrome oxidase histochemistry. Brain Res 171 (1979) 11-28
41. Wong-Riley M.T.T. Cytochrome oxidase: an endogenous metabolic marker for neuronal activity. Trends Neurosci 12 (1989) 94-101